Seattle, USA
BrainChild Bio was launched out of Seattle Children’s and founded on the work of Dr. Michael Jensen, a pioneer in the cancer immunotherapy field, and leverages over a decade of translational research, including FDA-authorized INDs covering four CNS CAR-T cell products. Our clinical pipeline will be accelerated by this foundational work, as we build a platform that integrates synthetic technologies to optimize the application of CAR-T cell therapies for CNS tumors.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for BrainChild Bio on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
